Literature DB >> 26605278

Accumulated myeloid-derived suppressor cells demonstrate distinct phenotypes and functions in two non-alcoholic steatohepatitis mouse models.

Hiromichi Tsunashima1, Koichi Tsuneyama1, Yuki Moritoki1, Masumi Hara1, Kentaro Kikuchi1.   

Abstract

BACKGROUND: To examine the steady state of hepatic myeloid-derived suppressor cells (MDSCs) and the lipid accumulation and inflammation-related changes in these cells, we analyzed the presence and functions of hepatic MDSCs in the following two non-alcoholic steatohepatitis (NASH) mouse models.
METHODS: Monosodium glutamate (MSG) model; MSG was subcutaneously injected into neonatal male C57BL/6J mice that were fed with normal diet up to 18 weeks of age. Methionine/choline-deficient diet (MCD) model; 16-week-old male C57BL/6J mice were fed with an MCD for 2 weeks. Those hepatic MDSCs were evaluated by flow cytometry and immunohistochemically.
RESULTS: Both MSG and MCD mice exhibited greater numbers of hepatic lipid droplets than 18-week-old male control mice. Hepatocellular ballooning was obvious in MSG, whereas inflammatory cell infiltration were apparent in MCD mice. CD11b, CD115, and Gr-1-positive hepatic MDSCs were increased in both models but higher in MCD mice, and demonstrated higher expression of an M2 macrophage marker CD206 mean fluorescence intensity (MFI) in MSG compared to MCD mice. Degree of reactive oxygen species production was evaluated using the DCFDA MFI values, which were significantly elevated in hepatic MDSCs from MCD mice. MSG mouse livers demonstrated Gr-1 positive cell accumulation around lipid droplets, mimicking crown-like structures in adipose tissues. In contrast, hepatic Gr-1 positive cells were primarily located in inflammatory cell aggregates in MCD mice.
CONCLUSIONS: These results suggest that hepatic fatty changes promote MDSC accumulation, and inflammatory changes induce phenotypic and functional alteration in hepatic MDSCs in NASH mouse models.

Entities:  

Keywords:  Myeloid-derived suppressor cells (MDSCs); non-alcoholic steatohepatitis (NASH)

Year:  2015        PMID: 26605278      PMCID: PMC4607837          DOI: 10.3978/j.issn.2304-3881.2015.04.08

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  20 in total

1.  Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics.

Authors:  Naoki Umemura; Masanao Saio; Tatsuhiko Suwa; Yusuke Kitoh; Juncheng Bai; Kenichi Nonaka; Guan-Feng Ouyang; Makoto Okada; Margit Balazs; Roza Adany; Toshiyuki Shibata; Tsuyoshi Takami
Journal:  J Leukoc Biol       Date:  2008-02-19       Impact factor: 4.962

2.  Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice.

Authors:  Yu Yamazaki; Isao Usui; Yukiko Kanatani; Yuji Matsuya; Koichi Tsuneyama; Shiho Fujisaka; Agussalim Bukhari; Hikari Suzuki; Satoko Senda; Shingo Imanishi; Kazuya Hirata; Manabu Ishiki; Ryuji Hayashi; Masaharu Urakaze; Hideo Nemoto; Masashi Kobayashi; Kazuyuki Tobe
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-09-01       Impact factor: 4.310

3.  The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease.

Authors:  Etsuko Hashimoto; Saturu Yatsuji; Hiroyuki Kaneda; Yoko Yoshioka; Makiko Taniai; Katsutoshi Tokushige; Keiko Shiratori
Journal:  Hepatol Res       Date:  2005-10-03       Impact factor: 4.288

4.  Spirulina improves non-alcoholic steatohepatitis, visceral fat macrophage aggregation, and serum leptin in a mouse model of metabolic syndrome.

Authors:  Makoto Fujimoto; Koichi Tsuneyama; Takako Fujimoto; Carlo Selmi; M Eric Gershwin; Yutaka Shimada
Journal:  Dig Liver Dis       Date:  2012-03-22       Impact factor: 4.088

Review 5.  Restoration of antitumor immunity through selective inhibition of myeloid derived suppressor cells by anticancer therapies.

Authors:  L Apetoh; F Végran; S Ladoire; F Ghiringhelli
Journal:  Curr Mol Med       Date:  2011-07       Impact factor: 2.222

6.  Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate.

Authors:  J W Olney
Journal:  Science       Date:  1969-05-09       Impact factor: 47.728

7.  Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus.

Authors:  S Chen; S M F Akbar; M Abe; Y Hiasa; M Onji
Journal:  Clin Exp Immunol       Date:  2011-07-15       Impact factor: 4.330

8.  Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome.

Authors:  Yoshiyuki Sasaki; Tsutomu Shimada; Seiichi Iizuka; Wataru Suzuki; Hiroko Makihara; Ryutaro Teraoka; Koichi Tsuneyama; Ryoji Hokao; Masaki Aburada
Journal:  Eur J Pharmacol       Date:  2011-05-01       Impact factor: 4.432

9.  Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response.

Authors:  Pratima Sinha; Virginia K Clements; Stephanie K Bunt; Steven M Albelda; Suzanne Ostrand-Rosenberg
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

10.  Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice.

Authors:  Shiho Fujisaka; Isao Usui; Agussalim Bukhari; Masashi Ikutani; Takeshi Oya; Yukiko Kanatani; Koichi Tsuneyama; Yoshinori Nagai; Kiyoshi Takatsu; Masaharu Urakaze; Masashi Kobayashi; Kazuyuki Tobe
Journal:  Diabetes       Date:  2009-08-18       Impact factor: 9.461

View more
  3 in total

1.  Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis.

Authors:  Atsuko Takai; Kentaro Kikuchi; Mayuko Ichimura; Koichi Tsuneyama; Yuki Moritoki; Kotaro Matsumoto; Hiromichi Tsunashima; Takeshi Onda; Noriyuki Kuniyoshi; Tomoyuki Nariyama; Sho Ohyatsu; Juri Kubota; Kozue Nagumo; Shinpei Sato; Masumi Hara; Hiroshi Miyakawa
Journal:  BMC Gastroenterol       Date:  2020-02-27       Impact factor: 3.067

Review 2.  Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC.

Authors:  Yueqi Zhang; Hongbing Wang; Hua Xiao
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

3.  Protective Effects of MitoTEMPO on Nonalcoholic Fatty Liver Disease via Regulating Myeloid-Derived Suppressor Cells and Inflammation in Mice.

Authors:  Jiayuan Wu; Li Zheng; Juanfen Mo; Xiujuan Yao; Chenliang Fan; Yi Bao
Journal:  Biomed Res Int       Date:  2020-07-30       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.